108 related articles for article (PubMed ID: 1895754)
1. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M
Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Khalaf W; Maina C; Byers J; Harvey W
Leuk Res; 2002 Feb; 26(2):169-77. PubMed ID: 11755467
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
[TBL] [Abstract][Full Text] [Related]
5. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
Ozes ON; Klein SB; Reiter Z; Taylor MW
Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
[TBL] [Abstract][Full Text] [Related]
6. Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia.
Romquin N; Billard C
Leukemia; 1995 Jan; 9(1):87-94. PubMed ID: 7845033
[TBL] [Abstract][Full Text] [Related]
7. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of an Epstein-Barr virus nuclear antigen-negative hairy cell line.
Lang AB; Odermatt BF; Gut DR; Rüttner JR
Exp Cell Biol; 1985; 53(2):61-8. PubMed ID: 2984056
[TBL] [Abstract][Full Text] [Related]
9. T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy-cell leukemia correlates with interferon-gamma production.
Jöhrens K; Moos V; Schneider T; Anagnostopoulos I
Leuk Lymphoma; 2009 Oct; 50(10):1687-92. PubMed ID: 19757302
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a new cell line (CJ18) from a patient with 'hairy' cell leukaemia.
Skinnider LF; Ha T; Bergen S; Wang HC
Scand J Haematol; 1985 Oct; 35(4):430-6. PubMed ID: 4081642
[TBL] [Abstract][Full Text] [Related]
11. CD25-negative hairy cell leukaemia: intracytoplasmic detection of Tac antigen and interferon-induced surface expression.
Tison T; Dazzi F; Giacon C; Vianello F; Valente ML; Radossi P; Sgarabotto D; Girolami A; Pennelli N; Poletti A
J Pathol; 1995 Sep; 177(1):41-7. PubMed ID: 7472778
[TBL] [Abstract][Full Text] [Related]
12. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
13. The origin of B-chronic lymphocytic leukaemia (B-CLL) and its relationship to hairy cell leukaemia (HCL).
Caligaris-Cappio F; Bergui L; Pizzolo G; Chilosi M; Tesio L; Campana D; Semenzato G; Malavasi F; Gobbi M
Adv Exp Med Biol; 1985; 186():949-56. PubMed ID: 3931438
[No Abstract] [Full Text] [Related]
14. Hairy cell leukemia: establishment of a cell line and its characteristics.
Miyoshi I; Hiraki S; Tsubota T; Hikita T; Masuji H; Nishi Y; Kimura I
Cancer; 1981 Jan; 47(1):60-5. PubMed ID: 6257373
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient.
Schiller JH; Bittner G; Meisner LF; Oberley TD; Norback D; Schwabe M; Faltynek CR; Raab-Traub N
Leukemia; 1991 May; 5(5):399-407. PubMed ID: 1851909
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a new cell line from a patient with hairy cell leukemia-Japanese variant.
Shibayama H; Machii T; Tokumine Y; Nishimori Y; Nojima J; Inoue R; Kanamaru A; Tagawa S; Kitani T
Leuk Lymphoma; 1997 Apr; 25(3-4):373-80. PubMed ID: 9168447
[TBL] [Abstract][Full Text] [Related]
19. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
[TBL] [Abstract][Full Text] [Related]
20. Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells.
Genot E; Wietzerbin J
Leuk Lymphoma; 1994; 14 Suppl 1():23-6. PubMed ID: 7820049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
